APP and Alzheimer disease: Indeed, although in AD patients, the main product of APP proteolytic process is Aβ, which derives from beta- and gamma-secretase activity, APP can be alternatively cleaved by alpha-secretase, leading to the formation of nonpathogenic Aα (Aα) peptides [133].